Sign In
Buy CC
$17.93
+0.82 (+4.79%)
At Close: Aug 04, 2026
Chemours (CC) Earnings and Revenues Top Estimates in Q1
01:36pm, Wednesday, 04'th May 2022 Zacks Investment Research
Chemours (CC) gains on strong volumes and higher prices amid headwinds from raw material cost inflation and logistics challenges in Q1.
Chemours (CC) Earnings and Revenues Top Estimates in Q1
11:19am, Wednesday, 04'th May 2022
Chemours (CC) gains on strong volumes and higher prices amid headwinds from raw material cost inflation and logistics challenges in Q1.
Chemours (CC) Q1 2022 Earnings Call Transcript
06:00pm, Tuesday, 03'rd May 2022 The Motley Fool
CC earnings call for the period ending March 31, 2022.
Why Chemours Stock Rallied as Much as 16% in Early Trading Today
02:41pm, Tuesday, 03'rd May 2022 The Motley Fool
The chemicals company reported earnings and investors were clearly pleased with the news.
The Chemours Company (CC) CEO Mark Newman on Q1 2022 Results - Earnings Call Transcript
01:00pm, Tuesday, 03'rd May 2022
The Chemours Company (NYSE:CC ) Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET Company Participants Mark Newman – President, Chief Executive Officer Sameer Ralhan – Senior Vice President,
Why Chemours Stock Rallied as Much as 16% in Early Trading Today
10:41am, Tuesday, 03'rd May 2022
The chemicals company reported earnings and investors were clearly pleased with the news.
Chemours (CC) Q1 Earnings and Revenues Beat Estimates
10:45pm, Monday, 02'nd May 2022 Zacks Investment Research
Chemours (CC) delivered earnings and revenue surprises of 58.70% and 14.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemours (CC) Q1 Earnings and Revenues Beat Estimates
08:18pm, Monday, 02'nd May 2022
Chemours (CC) delivered earnings and revenue surprises of 58.70% and 14.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemours stock rallies after Q1 beat, raised 2022 guidance
05:02pm, Monday, 02'nd May 2022
Shares of Chemours Co. CC, +0.09% jumped nearly 7% in the extended session Monday after the the chemicals company reported first-quarter earnings that beat Wall Street expectations, saying its "outsta
Scotts Miracle-Gro (SMG) to Post Q2 Earnings: What's in Store?
03:50pm, Friday, 29'th Apr 2022 Zacks Investment Research
ScottsMiracle-Gro's (SMG) Q2 performance is likely to have benefited from strength in the U.S. Consumer segment and cost savings.
Andersons (ANDE) to Report Q1 Earnings: What's in the Offing?
03:07pm, Friday, 29'th Apr 2022 Zacks Investment Research
Andersons's (ANDE) Q1 performance is likely to reflect benefits from strong demand and high commodity and fertilizer prices.
TimkenSteel (TMST) to Report Q1 Earnings: What's in the Cards?
01:30pm, Friday, 29'th Apr 2022 Zacks Investment Research
TimkenSteel (TMST) is expected to have benefited, in the first quarter, from higher demand in industrial and energy end markets.
DuPont (DD) Gears Up for Q1 Earnings: What's in the Offing?
01:26pm, Friday, 29'th Apr 2022 Zacks Investment Research
DuPont (DD) is likely to have benefited from strong demand and productivity actions. However, higher raw material and logistics costs are expected to have hurt its Q1 results.
Why Chemours (CC) Might Surprise This Earnings Season
12:48pm, Friday, 29'th Apr 2022 Zacks Investment Research
Chemours (CC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Will Higher Prices Benefit Nutrien (NTR) in Q1 Earnings?
12:03pm, Friday, 29'th Apr 2022 Zacks Investment Research
Higher prices aided by strong demand and tight supply are likely to have driven Nutrien's (NTR) sales and margins in the first quarter.
